











































An appraisal of respiratory system compliance in mechanically
ventilated covid-19 patients
Citation for published version:
COVID-19 Critical Care Consortium 2021, 'An appraisal of respiratory system compliance in mechanically
ventilated covid-19 patients', Critical Care, vol. 25, no. 1, pp. 199. https://doi.org/10.1186/s13054-021-
03518-4
Digital Object Identifier (DOI):
10.1186/s13054-021-03518-4
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:




Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 17. Aug. 2021
Li Bassi et al. Crit Care          (2021) 25:199  
https://doi.org/10.1186/s13054-021-03518-4
RESEARCH
An appraisal of respiratory system 
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Abstract 
Background: Heterogeneous respiratory system static compliance (CRS) values and levels of hypoxemia in patients 
with novel coronavirus disease (COVID-19) requiring mechanical ventilation have been reported in previous small-
case series or studies conducted at a national level.
Methods: We designed a retrospective observational cohort study with rapid data gathering from the international 
COVID-19 Critical Care Consortium study to comprehensively describe CRS—calculated as: tidal volume/[airway 
plateau pressure-positive end-expiratory pressure (PEEP)]—and its association with ventilatory management and 
outcomes of COVID-19 patients on mechanical ventilation (MV), admitted to intensive care units (ICU) worldwide.
Results: We studied 745 patients from 22 countries, who required admission to the ICU and MV from January 14 to 
December 31, 2020, and presented at least one value of CRS within the first seven days of MV. Median (IQR) age was 62 
(52–71), patients were predominantly males (68%) and from Europe/North and South America (88%). CRS, within 48 h 
from endotracheal intubation, was available in 649 patients and was neither associated with the duration from onset 
of symptoms to commencement of MV (p = 0.417) nor with  PaO2/FiO2 (p = 0.100). Females presented lower CRS than 
males (95% CI of CRS difference between females-males: − 11.8 to − 7.4 mL/cmH2O p < 0.001), and although females 
presented higher body mass index (BMI), association of BMI with CRS was marginal (p = 0.139). Ventilatory manage-
ment varied across CRS range, resulting in a significant association between CRS and driving pressure (estimated 
decrease − 0.31  cmH2O/L per mL/cmH20 of CRS, 95% CI − 0.48 to − 0.14, p < 0.001). Overall, 28-day ICU mortality, 
accounting for the competing risk of being discharged within the period, was 35.6% (SE 1.7). Cox proportional hazard 
analysis demonstrated that CRS (+ 10 mL/cm  H2O) was only associated with being discharge from the ICU within 
28 days (HR 1.14, 95% CI 1.02–1.28, p = 0.018).
© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which 
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the 
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or 
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line 
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory 
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this 
licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/. The Creative Commons Public Domain Dedication waiver (http:// creat iveco 
mmons. org/ publi cdoma in/ zero/1. 0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Open Access
*Correspondence:  g.libassi@uq.edu.au
†Gianluigi Li Bassi and Jacky Y. Suen have equally contributed to this work
1 Critical Care Research Group, The Prince Charles Hospital, Chermside, 
Australia
Full list of author information is available at the end of the article
Page 2 of 22Li Bassi et al. Crit Care          (2021) 25:199 
Background
Millions of people have been infected by SARS-CoV-2 
worldwide, and many of those have been hospitalized 
for respiratory complications associated with coronavi-
rus disease-2019 (COVID-19). Many of those COVID-19 
hospitalised patients have received mechanical ventila-
tion (MV), due to the development of acute hypoxemic 
respiratory failure and acute respiratory distress syn-
drome (ARDS) [1–4]. To date, several landmark studies 
[5–8] have improved our understanding of COVID-19 
pulmonary pathophysiology, but pulmonary derange-
ment in COVID-19 and appropriate ventilatory manage-
ment remains incompletely characterized.
Earlier reports on the pulmonary pathophysiology 
of COVID-19 patients reported conflicting results and 
extreme heterogeneity in levels of pulmonary shunting, 
static respiratory system compliance (CRS), [9–12] and 
substantial heterogeneity in lung recruitability [13, 14]. 
Adding further to the controversy over CRS in COVID-19 
patients, Grasselli and collaborators [7] have compared 
findings from an Italian repository of COVID-19 ARDS 
with previous ARDS cases of different etiologies. They 
found statistically significant higher CRS in patients with 
COVID-19 ARDS. In addition, they found that patients 
who presented with lower CRS and higher D-dimer values 
had the greatest mortality risk. In line with these figures, 
in a small-case series, Chiumello and collaborators found 
that COVID-19 patients presented higher CRS levels in 
comparison with patients with ARDS from other etiolo-
gies and matched levels of hypoxemia [12]. Regrettably, 
those previous reports did not provide any informa-
tion on how CRS progressed beyond a punctual assess-
ment during the period of MV. In contrast, in another 
landmark study by Ferrando et  al. [6], CRS figures from 
a Spanish database were very similar to previously pub-
lished cohorts of ARDS patients. The authors also found 
that intensive care unit (ICU) discharge and mortality 
were not influenced by the initial levels of CRS.
In a pandemic caused by a novel virus, access to 
international data is vital, because it may help account 
for differences in populations, access to medical care, 
equipment and critical variations in clinical manage-
ments among countries. Thus, analysis of international 
repositories improves the overall understanding of a 
novel disease and helps establishing best practices to 
enhance outcome. One example of how single-center or 
single-country studies can influence medical care early 
in a pandemic, before being contradicted by subsequent 
international findings is the issue of CRS. Indeed, as this 
parameter can be markedly impacted by fine variations 
in ventilatory management, extrapolations from mono-
center or single-country studies may be challenging. In 
early January 2020, the COVID-19 Critical Care Con-
sortium incorporating the ExtraCorporeal Membrane 
Oxygenation for 2019 novel Coronavirus Acute Respira-
tory Disease (COVID-19–CCC/ECMOCARD) group 
was founded to investigate patients presenting to ICUs 
worldwide.
Here, we present a comprehensive appraisal of CRS in 
mechanically ventilated COVID-19 patients enrolled 
into the COVID-19–CCC/ECMOCARD international 
study, in order to understand the dynamics of CRS during 
the first week of mechanical ventilation and its potential 
impact on patient outcomes.
Materials and methods
Study design and oversight
The COVID-19-CCC/ECMOCARD is an international, 
multicentre, cohort observational study ongoing in 351 
hospitals across 53 countries. The full study protocol is 
available elsewhere [15]. To summarize, participating 
hospitals obtained local ethics committee approval and 
a waiver of informed consent was granted in all cases. 
ISARIC/SPRINT-SARI data collection began at admis-
sion to hospital, while data collection for the COVID-19–
CCC observational study commenced at admission to the 
ICU. De-identified patient data were collected retrospec-
tively and stored via the REDCap electronic data capture 
tool, hosted at the University of Oxford, United Kingdom 
or Monash University, Melbourne, Australia.
Study population
We reviewed data of all patients admitted to the ICU 
at a COVID-19–CCC collaborating site, from Janu-
ary 14 through September 30, 2020, with a clinically 
suspected or laboratory confirmed diagnosis of SARS-
CoV-2 infection, through naso-pharyngeal swab for real-
time PCR SARS-CoV-2 detection. Of note, suspicion 
Conclusions: This multicentre report provides a comprehensive account of CRS in COVID-19 patients on MV. CRS 
measured within 48 h from commencement of MV has marginal predictive value for 28-day mortality, but was associ-
ated with being discharged from ICU within the same period. Trial documentation: Available at https:// www. covid- 
criti cal. com/ study.
Trial registration: ACTRN12620000421932.
Keywords: Mechanical ventilation, Compliance, ARDS, COVID-19, SARS-CoV-2
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of SARS-CoV-2 infection was based on symptoms and 
onset of infection and was confirmed by the clinician 
when COVID-19 infection was the most likely cause of 
the symptoms experienced. Patients excluded were those 
under the age of 15 years or admitted to an ICU for other 
reasons. We focused our analysis on patients on con-
trolled MV and with a computed CRS value within 48 h of 
MV commencement.
Definitions and pulmonary mechanics computations
CRS was calculated as: tidal volume (mL)/[(airway plateau 
pressure-PEEP  (cmH2O))]. Of note, we provided to data 
collectors a detailed data dictionary, with instructions 
on how to collect airway plateau pressure values, via an 
inspiratory pause of approximately 3  s. We computed 
CRS using the first measured tidal volume, airway plateau 
pressure and PEEP values, within 48 h of MV commence-
ment. In the sub-population of patients on controlled 
MV, without ECMO support, we analysed key pulmonary 
variables, such as tidal volume, positive end expiratory 
pressure (PEEP), static driving pressure, inspiratory frac-
tion of oxygen  (FiO2), and gas exchange, recorded dur-
ing routine clinical practice and only. Tidal volume was 
reported in mL/kg of predicted body weight (PBW) [16].
Data collection
After enrolment, data on demographics, comorbidities, 
clinical symptoms and laboratory results were collected 
by clinical and research staff of the participating ICUs in 
an electronic case report form [15]. Details of respiratory 
and hemodynamic support, physiological variables, and 
laboratory results were collected daily. Of note, the worst 
daily values were preferentially recorded. The duration of 
MV and ICU stay, and hospital mortality were recorded. 
Analysis of daily data was restricted to the first seven 
days from commencement of MV.
Statistical analyses
Descriptive statistics summarised demographics, clinical 
signs on ICU admission, ICU management and clinical 
outcomes for the overall study cohort and subjects with 
baseline compliance measured within the first 48  h of 
controlled MV. Statistics were reported as medians (inter-
quartile range) for continuous variables and numbers 
(percentage) for categorical variables. Linear regression 
was applied to summarise associations between baseline 
compliance with body mass index (BMI) (including inter-
action between BMI and sex), days from symptom onset 
to MV commencement and  PaO2/FiO2, adjusted for BMI. 
Linear mixed modelling was used to investigate trends in 
compliance over time and associations with key respira-
tory parameters during the first 7 days of controlled MV. 
Models assumed a linear effect for days and a random 
intercept per subject to account for repeated measures. 
Consistent with exploratory analyses, BMI was included 
as a fixed effect to adjust for potential confounding in 
the clinical characteristics and management of patients 
with different BMI. Hypothesis testing was applied to 
all fixed effects, assuming a 5% level of statistical signifi-
cance. Results were summarised graphically with uncer-
tainty in estimated trends represented by 95% prediction 
intervals. Expected patient outcomes including length 
of ICU stay, duration of MV and risk of ICU mortality 
versus discharge were examined using multi-state mod-
elling [17]. Compared with exploratory analyses of clini-
cal outcomes, the multistate model accounted for ICU 
discharge and death as competing events and allowed 
data from all patients to be included, regardless of study 
follow-up time. The model comprised of four states, to 
describe patients prior to commencement of MV (non 
MV), on mechanical ventilation (MV), ICU discharged 
(Discharge) and mortality (Death). States were presented 
as percentage and standard error (SE) in the text. Patients 
extubated before death or discharge were assumed to 
transition between MV an non-MV states. State transi-
tions were modelled by Cox proportional hazards, with 
patients censored at last known follow-up, up to 28 days 
from ICU admission. Follow-up analysis considered Cox 
proportional hazard regression to examine associations 
between baseline compliance and competing risks of ICU 
mortality and discharge, following commencement of 
MV. Baseline compliance was included as a linear effect, 
with age, sex, BMI and comorbidities (hypertension, 
chronic cardiac disease, chronic kidney disease) as addi-
tional covariates and adjusted for recruiting centre. A 
shared frailty term (Gamma distributed) was included to 
account for residual variation between study sites. Analy-
ses were conducted using R version 3.6.2 or higher (The 
R Foundation).
Results
We studied 745 patients from 22 countries, who required 
admission to the ICU and MV from January 14 to 
December 31, 2020, and presented at least one value of 
CRS within the first seven days of MV. Among those, 597 
(80%) had laboratory-confirmed diagnosis of SARS-CoV2 
infection, while in 148 (20%), infection was clinically sus-
pected. Enrolment rate, since January 2020, is reported in 
Fig. 1. CRS, within 48 h from endotracheal intubation, was 
available in 649 patients (Fig. 2). No association between 
CRS and days from onset of symptoms to commencement 
of MV was found (Fig. 3). Median CRS (IQR), within the 
first 48 h of mechanical ventilation, was 34.1 mL/cmH2O 
(26.4–44.0) and  PaO2/FiO2 113.0  mmHg (84.0–161.3), 
without any linear association between these parameters. 
In particular, 16%, 46% and 38% of the patients presented 
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Fig. 1 Patient enrolment rate from January 14 through December 31, 2020
Fig. 2 Patient population flow chart. The analysis of 1505 COVID-19 patients on mechanical ventilation identified 649 patients with static 
respiratory system compliance within 48 h from commencement of mechanical ventilation
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with mild, moderate or severe hypoxemia, respectively 
(Fig.  4a). Female sex was associated with a significantly 
lower CRS than in males (95% CI of difference between 
genders: − 11.8 to − 7.4 mL/cmH2O p < 0.001) (Fig. 4b). 
Females also presented higher body mass index (BMI) 
(95% CI of difference between males and females: − 1.9 
to − 5.5, p < 0.001), but as shown in Fig. 5, CRS and BMI 
were not linearly associated. Our model estimated that 
CRS was 37.57  cmH2O/mL (95% CI 36.5–38.6) upon 
commencement of MV (Fig.  6), with further worsening 
in the first seven days of MV (estimated decrease − 0.31 
 cmH2O/mL per day, 95% CI − 0.48 to − 0.14, p < 0.001). 
In addition, as detailed in Fig.  7,  PaCO2, tidal volume, 
PEEP, driving pressure and  FiO2 significantly varied 
across the range of CRS, and a significant association 
was found between inspiratory plateau pressure and CRS 
changes (Fig. 8).
Baseline characteristics upon ICU admission, applied 
interventions and outcomes, are summarized in Table 1. 
The most common interventions applied to the study 
population were use of antibiotics (96%), neuromuscu-
lar blocking agents (81%) and prone position (61%). The 
overall hospital mortality of the study population was 
40%, and among those patients who died in the hospital 
or were discharged alive, the median (IQR) duration of 
MV was 11 days (6–18) and 14 days (8–23), respectively. 
Overall, 28-day ICU mortality, accounting for compet-
ing risks, was 35.6% (SE 1.7) and estimated 28-day mor-
tality from commencement of MV was 37.1% (SE 1.7) 
(Fig. 9b). Cox proportional hazard analysis (Fig. 9c) dem-
onstrated that age (hazard ratio 1.37, 95% CI 1.19–1.59, 
p < 0.001) and chronic cardiac diseases (HR 1.62, 95% CI 
1.14–2.29, p < 0.001) were the only baseline factors asso-
ciated with 28-day mortality risk. In addition, age (HR 
0.77, 95% CI 0.66–0.83, p < 0.001), male sex (HR 0.59, 95% 
CI 0.44–0.79, p < 0.001), BMI (HR 0.86, 95% CI 0.79–0.95, 
p = 0.003) and CRS (+ 10 mL/cm  H2O) (HR 1.14, 95% CI 
1.02–1.28, p = 0.018) were associated with the chance of 
being discharge from the ICU within 28 days.
Fig. 3 Linear regression analysis of days from onset of symptoms to commencement of mechanical ventilation and static respiratory system 
compliance, based on the first measurement obtained within 48 h from commencement of mechanical ventilation, adjusted for body mass index. 
Dark black horizontal bar depicts median value, and upper and lower horizontal light black bars show 90th and 10th percentile. Days of onset of 
symptoms to commencement of mechanical ventilation was not associated with static respiratory system compliance (estimate 0.92 mL/cmH2O, 
95% CI − 0.31–0.31 p = 0.417)
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Discussion
This large observational report from intensive care units 
throughout the world found that initial static respira-
tory system compliance was only associated with hazard 
of being discharged from the ICU within 28  days. The 
duration from onset of symptoms to commencement of 
MV did not influence CRS, and interestingly lower CRS 
was found in female patients. In the evaluated popula-
tion, neuromuscular blocking agents and prone position 
were commonly applied and ventilatory management 
Fig. 4 a Linear regression analysis of arterial partial pressure of oxygen  (PaO2/FiO2) and respiratory system compliance (CRS), based on the first 
measurement obtained within 48 h from commencement of mechanical ventilation, with an interaction of gender and adjusted for body mass 
index (BMI). No statistically significant association was found between  PaO2/FiO2 and CRS (estimate 0.49, 95% CI − 0.09–1.07 p = 0.100). Typical acute 
respiratory distress syndrome stratification groups [35] (severe, moderate and mild based on levels of hypoxemia) are highlighted in dark, medium 
and light grey, respectively. b Static respiratory system compliance (CRS) distribution by sex, based on the first measurement obtained within 48 h 
from commencement of mechanical ventilation. Dashed black lines depict median values for females and males
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Fig. 5 Linear regression analysis of static respiratory system compliance, based on the first measurement obtained within 48 h from 
commencement of mechanical ventilation, and body mass index with an interaction for sex. Per each graph, fitted line of the model is depicted and 
the upper and lower lines display the 95% predictive interval. Dark grey dots depict female patients, while light grey dots males. Static respiratory 
system compliance did not vary according to the body mass index (estimate − 0.12  cmH2O/mL, 95%CI − 0.29 to − 0.04, p = 0.139), but was 
associated with female sex (estimate − 10.73  cmH2O/mL, 95%CI − 18.54 to − 2.92, p = 0.007)
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across CRS levels varied in terms of tidal volume, PEEP 
and  FiO2, throughout the first 7 days of MV.
In comparison with previous reports on ARDS patients 
without COVID-19 [18], we similarly found that the 
majority of patients exhibited moderate hypoxemia, even 
when presented higher CRS. We also noted a larger range 
of CRS in line with previous studies [7, 8], but in contrast 
with values from a larger COVID-19 ARDS series from 
Spain [6]. Considering that we focused our analysis on 
static compliance of the respiratory system, without par-
titioning into the pulmonary and chest wall components 
[19, 20], it is interesting that CRS was not associated with 
BMI, suggesting that patients with higher BMI poten-
tially presented also with higher lung compliance. Irre-
spective, we found lower CRS in female patients, who also 
presented higher BMIs. To the best of our knowledge, 
no studies have systematically investigated the effects of 
gender/BMI on COVID-19 severity; thus, whether obe-
sity might be a crucial risk factor for ICU admission and 
mechanical ventilation, specifically in female patients, 
and its effects on lung compliance should be further 
explored. We also found that throughout the range of 
CRS values, plateau pressure was within what is typically 
presumed as lung protective ranges [21], but this resulted 
in potentially harmful driving pressures, specifically for 
patients with the lowest CRS values. As many of these 
patients were obese, this raises the question of whether 
these modest pressures might have increased the risk 
of pulmonary derecruitment, or in patients with nor-
mal BMI, the resulting driving pressure might have been 
related to pulmonary overdistention. These factors could 
have contributed to sustained hypoxemia and impaired 
lung function throughout the study period. In such cir-
cumstances, it is questionable whether MV guided by 
oesophageal pressure monitoring may have some bene-
fits [22], but more research is needed to corroborate such 
reasoning.
Phenotypic subsets of COVID-19-associated ARDS 
have been proposed [9, 13, 23–25]. Recent study has 
also explored whether CRS—related phenotype patterns 
existed among patients with ARDS before the COVID-19 
pandemic [26]. Various investigators [7, 27], who did not 
find significant CRS variability among COVID-19 patients 
requiring MV, questioned the overall clinical value of 
CRS in the COVID-19 population. In a very small case 
series, Gattinoni et al [9] found an initial CRS of 50 mL/
cmH2O, but high levels of shunt fraction that could have 
explained the resulting severe hypoxemia. In subsequent 
study, Chiumello and collaborators found higher CRS in 
patient with COVID-19 ARDS and ARDS caused by 
Fig. 6 Static respiratory system compliance dynamics. Evolution of static respiratory system compliance over the first 7 days of mechanical 
ventilation, adjusted for body mass index. Under each day, the number of analysed patients is reported in parenthesis. Fitted line of the model is 
depicted, and the upper and lower lines display the 95% predictive interval. Respiratory system compliance varied during the first seven days of 
mechanical ventilation (estimate − 0.31  cmH2O/mL, 95%CI − 0.48 to 0.14, p < 0.001)
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Fig. 7 Linear Mixed model analysis of respiratory system compliance vs. crucial pulmonary variables during the first 7 days of mechanical 
ventilation (grey-scale coded bar for day 1 through 7 is reported on the right section of each graph and in parenthesis is reported the number 
of analysed patients). Per each graph, fitted line of the model is depicted and the upper and lower lines display the 95% predictive interval. All 
analyses are adjusted for body mass index. Static compliance of respiratory system was found to be associated with  PaCO2 (estimated decrease 
− 0.11 mmHg, 95% CI − 0.15 to − 0.06, p < 0.001), tidal volume (estimated increase 0.04 mL/Kg of predicted body weight per day, 95% CI 0.03–0.04, 
p < 0.001), PEEP (estimated increase − 0.03  cmH2O, 95% CI 0.02–0.04, p < 0.001), driving pressure (estimated decrease − 0.31  cmH2O/L, 95% CI − 0.48 
to 0.14, p < 0.001) and  FiO2 (estimated decrease − 0.15%, 95% CI − 0.23 to − 0.06, p < 0.001). While  PaO2/FiO2, was not significantly associated with 
static compliance of respiratory system (estimated increase 0.29 mmHg, 95% CI − 0.03 to 0.61, p = 072)  PaO2/FiO2, ratio between arterial partial 
pressure of oxygen and inspiratory fraction of oxygen;  PaCO2 arterial partial pressure of carbon dioxide; PEEP, positive end-expiratory pressure
Fig. 8 Association of airway inspiratory plateau pressure with static respiratory system compliance. Linear Mixed model analysis of the association 
of respiratory system compliance with airway inspiratory plateau pressure during the first 7 days of mechanical ventilation (grey-scale coded bar 
for day 1 through 7 is reported on the right section of each graph and in parenthesis is reported the number of analysed patients). Fitted line of the 
model is depicted, and the upper and lower lines display the 95% predictive interval. Analysis is adjusted for body mass index. The model highlights 
significant association between respiratory system compliance and airway plateau pressure (estimated decrease − 0.22  cmH2O/L, 95% CI − 0.23 to 
− 0.21, p < 0.001), but based on the model prediction, airway plateau pressure remained predominantly below 30  cmH2O
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Table 1 Only patients with the following characteristics were included in this analysis: (1) on controlled mechanical ventilation; (2) 
airway plateau pressure, tidal volume and positive-end-expiratory pressure recorded within 48 h from commencement of mechanical 
ventilation
Characteristic Full cohort (n = 745) First CRS recorded 
within 48 hr of MV 
(n = 649)
Age, years: n; median (IQR) 745; 62 (52–71) 649; 62 (53–71)
Male: n (%) 510 (68) 445 (69)
Geographic region: n (%)
 Africa 19 (3) 14 (2)
 Asia 63 (8) 57 (9)
 Australia and New Zealand 6 (1) 4 (1)
 Europe 326 (44) 295 (45)
 Latin America and the Caribbean 108 (14) 92 (14)
 Northern America 223 (30) 187 (29)
Time from onset of symptoms, days: n; median (IQR)
Onset of symptoms to hospital admission 735; 7 (3–9) 643; 7 (3–9)
Onset of symptoms to ICU admission 735; 7 (5–11) 643; 7 (5–11)
Onset symptoms to mechanical ventilation 735; 8 (5–11) 643; 8 (5–11)
Clinical signs on ICU admission: n; median (IQR)
WBC count,  103/µL 604; 8.9 (6.3–12.8) 540; 9.0 (6.6–13.0)
Lymphocyte count,  103 459; 0.7 (0.5–1.1) 402; 0.7 (0.5–1.1)
Temperature, °C 329; 37.4 (36.5–38.1) 293; 37.4 (36.5–38.2)
Creatinine, mg/dL 613; 1.0 (0.7–1.4) 543; 1.0 (0.7–1.4)
CRP, mg/dL 216; 118.1 (29.4–206.7) 194;121 (29.1–205.6)
Lymphocyte count to CRP ratio 167; 0.01 (0–0.03) 147; 0.01 (0–0.03)
Neutrophil to Lymphocyte ratio 414; 10.1 (5.6–16.6) 364;10.2 (5.9–16.6)
D-dimer level mg/L 237; 1.3 (0.8–4.7) 207; 1.4 (0.8–4.4)
Clinical management during first 28 days of ICU admission: n (%)
Antibiotics 713 (96) 621 (96)
Antivirals 288 (50) 245 (49)
Continuous renal replacement therapy 110 (15) 92 (15)
Vasoactive drugs 411 (58) 365 (58)
Cardiac-assist devices 54 (7) 48 (7)
ECMO 72 (10) 61 (9)
Prone positioning 451 (61) 392 (60)
Inhaled nitric oxide 72 (10) 66 (10)
Neuromuscular  blockadea 599 (81) 524 (81)
Recruitment manoeuvres 295 (40) 266 (41)
Clinical outcomes
Outcome at study end: n (%)
 Died in hospital 300 (40) 266 (41)
 Discharged alive 400 (54) 339 (52)
 Transferred to another facility 7 (1) 7 (1)
 Still in hospital/outcome not finalised 38 (5) 37 (6)
Died in hospital
 Duration of ICU stay, days: n; median (IQR) 300; 12 (6–20) 266; 12 (6–20)
 Duration of hospital stay, days: n, Median (IQR) 294; 13 (7–22) 260; 14 (7–22)
 Duration of MV, days: n; Median (IQR) 300; 11 (6–18) 266; 11 (5–18)
 Died within 28 days from ICU admission: n (%) 258 (86) 231 (87)
Discharged alive
 Duration of ICU stay, days: n; median (IQR) 399; 19 (12–30) 339; 19 (11–3)
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other injuries, while matching for similar levels of  PaO2/
FiO2 [12]. Interestingly, these findings were in line with 
computed tomography studies results, corroborating 
higher proportion of normally aerated tissue in COVID-
19 ARDS. In similar reports, heterogeneous pathophysi-
ology among patients with different levels of pulmonary 
compliance has been implied [10, 25]. As corroborated 
by landmark post-mortem studies [28] and clinical stud-
ies [7, 29], SARS-CoV-2 heterogeneously affects pulmo-
nary ventilation and perfusion. Hence, it could be argued 
that the use of CRS as key pathophysiological parameter 
to predict clinical evolution might be over simplistic and 
in-depth characterization of pulmonary pathophysiology 
should be recommended for COVID-19 patients, specifi-
cally when obese. Interestingly, our report is the first that 
specifically focused on the dynamics of CRS, rather than 
only baseline CRS. We found that CRS was not related to 
the duration from the onset of symptoms to commence-
ment of MV, emphasising the need for inclusive data on 
mechanisms of lung injury in not ventilated COVID-19 
patients [30]. The median CRS value found in our popula-
tion was 34.1 mL/cmH2O, similar to findings by Ferrando 
et  al. [6], not dissimilar to findings by Bellani et  al. on 
patients with non-COVID-19 ARDS [31], but lower than 
figures recently reported by Grasselli [7] and Grieco [32] 
in COVID-19 patients. In addition, we found a further 
decrease in CRS during the first week of MV. This could 
have been related to the specific ventilatory management 
in our reported population, but such discrepancy further 
highlights the need of a comprehensive appraisal of pul-
monary and chest wall mechanics in COVID-19 patients 
[20].
One of the most striking results was the continued 
use of high PEEP over the first seven days of MV, even 
in patients with high compliance. This seems counter-
intuitive, given that current recommendations in ARDS 
suggest decreasing PEEP, especially in the face of high 
compliance. As hypoxemia persisted even with high PEEP 
and high compliance, our results add to the hypothesis 
that maintaining high PEEP may worsen gas exchange 
from lung overdistension, resulting in increased dead 
space and intrapulmonary shunting. Other authors have 
speculated that using high levels of PEEP in COVID-19 
patients with low recruitability may be detrimental, and 
that lowering PEEP may improve gas exchange and limit 
ventilator-induced lung injury [33]. Our results in this 
large cohort of patients from multiple global areas sup-
port this theory. Finally, we found that patients required 
two weeks of MV, and 28-day mortality in the overall 
population was 35.6%, with hospital mortality up to 40%. 
These figures are in line with mortality rates reported 
by Grasselli [7] in the subgroups characterized by low 
D-dimer, and mortality in severe-moderate COVID-19 
ARDS, as corroborated by Ferrando [6]. Nevertheless, 
we found that CRS was only associated with the discharge 
from ICU within 28  days. Thus, the marginal clinical 
Percentages are calculated for non-missing data
CRS, static compliance of respiratory system; CRP, c-reactive protein; MV, mechanical ventilation; ICU, intensive care unit; IQR, interquartile range; ECMO, extracorporeal 
membrane oxygenation
a Administration of neuromuscular blockade drugs administered during the first day of invasive mechanical ventilation was not included in the analysis
Table 1 (continued)
Characteristic Full cohort (n = 745) First CRS recorded 
within 48 hr of MV 
(n = 649)
 Duration of hospital stay, days: n; Median (IQR) 396; 30 (21–46) 336; 30 (21–45)
 Duration of MV, days: n; Median (IQR) 400; 14 (8–23) 339; 14 (8–23)
 Discharged alive within 28 days from ICU admission: n (%) 195 (49) 165 (49)
(See figure on next page.)
Fig. 9 Multistate modelling and Cox regression analysis outcomes for patient with static compliance recorded within 48 h of commencing 
mechanical ventilation. a Multistate model structure for estimating expected outcomes up to 28 days from admission to intensive care unit (ICU). 
Modelled health states include not on invasive mechanical ventilation (non-MV), on mechanical ventilation (MV), ICU discharge and death. Patients 
start in the non-MV state if not mechanically ventilated upon or prior to ICU admission, or in the MV state otherwise. b Predicted probabilities of 
occupying health states up to 28 days from ICU admission. c Results of Cox proportional hazards modelling for risk of death and ICU discharge from 
commencement of mechanical ventilation. Covariates comprise age, body mass index (BMI), selected comorbidities (hypertension, chronic cardiac 
disease, chronic kidney disease) and baseline static compliance. Parameter estimates are presented as estimated hazard ratios with 95% confidence 
intervals (CI). Further details on factors significantly associated with assessed outcomes are available in the results section
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value of CRS as a predictor of mortality in COVID-19 
patients calls for urgent identification of valuable mark-
ers that could inclusively describe pulmonary derange-
ment and guide personalized treatment.
Strengths and limitations
Collaborations between international data collection 
efforts have the ability to answer many questions related 
to COVID 19 and to pave the way for future novel dis-
eases to achieve rapid and global data access to help 
guide best practice. The international COVID-19 Criti-
cal Care Consortium study [15], in collaboration with 
the ISARIC/SPRINT-SARI networks [34], provides infer-
ences not limited by ventilatory management specific to 
small patient cohort or single-country studies. In addi-
tion, in comparison with previous studies, we provided 
more granular data to inclusively appraise the dynam-
ics of CRS in COVID-19 patients on MV and to study its 
association with laboratory, and clinical features. A few 
limitations of our observational study should also be 
emphasized. First, we centred our analysis on COVID-19 
patients, without comparisons against previous reposito-
ries of patients with ARDS from different aetiologies. Yet, 
we provided a wide-ranging discussion of the character-
istics of our population in the context of previous analy-
ses in ARDS patients. Second, inferences on pulmonary 
perfusion disorders in our population can only be specu-
lative, since D-dimer was only available in a small subset 
of patients (Table  1). Third, as reported by the enrol-
ment rate (Fig. 1 Supplemental Digital Content), patients 
were mostly enrolled in the early phase of the pandemic, 
hence extrapolations from our findings should take into 
account potential biases related to overwhelmed criti-
cal care services. Fourthly, it is important to emphasise 
that we centred our analysis on CRS, but due to the com-
plex respiratory pathophysiology in COVID-19 patients 
and the high percentage of patients with increased BMI, 
the use of oesophageal pressure monitoring to fully 
describe lung and chest wall compliances is advisable 
and should be prioritised in future investigations. Fifth, 
the majority of patients were admitted in centers located 
in North America, Europe and South America. Although 
these findings are in line with the global distribution of 
COVID-19 cases, extrapolations of our findings in other 
regions should be applied cautiously.
Conclusions
Our comprehensive appraisal of COVID-19 patients on 
MV from a large international observational study implies 
that expected CRS within 48  h from commencement 
of MV is not influenced by the duration from onset of 
symptoms to commencement of MV, but after intuba-
tion, a further decrease in CRS might be expected during 
the first week of ventilation. In addition, baseline CRS is 
associated with the chance of being discharged from the 
ICU within 28 days, but it is not a predictive marker of 
28-day mortality. Based on potential inferences from our 
findings, future studies that could provide an in-depth 
characterization of lungs and chest wall compliance in 
COVID-19 patients will be critical to guide best practice 
in ventilatory management.
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